Select your language

Other official information and services: www.belgium.be  belgium

  • Key figures
  •  Data
  • Graphics
  • Comments
PRESCRIBERS
Main prescribers: 10580 - Specialists in internal medicine 93.46%
INSURED CONSUMERS
% of insured consumers 0.18%
Median age 52 years
Max/min ratio of the median age (by district) 1.40
Percentage of women 50.55%
Ratio Preferential scheme/General scheme 1.65
Coefficient of variation (2022) 54.23
Max/min ratio of % of insured consumers (by district) 7.30
CONSUMPTION
Annual consumption (DDD) 463,132
Consumption of DDD (per 100,000 insured persons) 4,024.12
% DDD issued outside the insurance (approximate) 10.28%
Average annual consumption per insured consumer (DDD) 22.75
% of insured consumers with > 3 times the average consumption 6,16%
Coefficient of variation 2013-2015 30.48
Coefficient of variation 2020-2022 47.75
Trend 2013-2022 -7.35%
Trend 2013-2019 -5.00%
Trend 2019-2022 -11.88%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance 466,997
Average annual expenditure per insured person 0.04
Average patient share per insured consumer 30.17%
Max/min ratio of expenditure per insured person (by disctrict) 8.06
% “Low-cost” medication 91.49%
Trend 2013-2022 -9.85%
Trend 2019-2022 -7.01%


On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

CODES (ATC-5) LABELS
J01AA TETRACYCLINES
J01BA AMPHENICOLS
J01CA PENICILLINS WITH EXTENDED SPECTRUM
J01CE BETA-LACTAMASE SENSITIVE PENICILLINS
J01CF BETA-LACTAMASE RESISTANT PENICILLINS
J01CR COMBINATIONS OF PENICILLINS, INCL. BETA-LACTAMASE INHIBITORS
J01DB FIRST-GENERATION CEPHALOSPORINS
J01DC SECOND-GENERATION CEPHALOSPORINS
J01DD THIRD-GENERATION CEPHALOSPORINS
J01DH CARBAPENEMS
J01EE COMBINATIONS OF SULFONAMIDES AND TRIMETHOPRIM, INCL. DERIVATIVES
J01FA MACROLIDES
J01FF LINCOSAMIDES
J01GB OTHER AMINOGLYCOSIDES
J01MA FLUOROQUINOLONES
J01XA GLYCOPEPTIDE ANTIBACTERIALS
J01XB POLYMYXINS
J01XE NITROFURAN DERIVATIVES
J01XX OTHER ANTIBACTERIALS

The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.

Click below to see the graph illustrating the evolution of the breakdown by volume of ATC codes used for the rates.

Antibiotics - Internal medicine (2022)

No selection

Internal medicine (except in training)

2022

  • ATC codesATC codes
  • Age Sex CVAge, sex and CV
  • Rates by sexRates by sex
  • Reimbursement rateReimbursement rate
  • TrendsTrends by region
  • Trends breakTrends break
  • Dot PlotDot Plot
  • Funnel PlotFunnel plot
  • Provincial consumptionDDD per patient by province
  • DDD patientQuantity per patient
  • MapDistribution map
  • Low-costLow-cost DDD


WE ARE INTERESTED IN YOUR OPINION

Do you have any experience in this area ? We listen to you !

Send us an email

   Download the full report
 Download the methodology